---
document_datetime: 2024-11-14 11:10:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/yorvipath-epar-all-authorised-presentations_en.pdf
document_name: yorvipath-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0694164
conversion_datetime: 2025-12-31 07:56:59.101391
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength       | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                 | Content (concentration)   | Pack size                      |
|------------------|-------------------|----------------|------------------------|---------------------------|-------------------------------------|---------------------------|--------------------------------|
| EU/1/23/1766/001 | Yorvipath         | 168 µg/0.56 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.56 ml (0.3 mg/ml)       | 2 pre-filled pens + 30 needles |
| EU/1/23/1766/002 | Yorvipath         | 294 µg/0.98 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.98 ml (0.3 mg/ml)       | 2 pre-filled pens + 30 needles |
| EU/1/23/1766/003 | Yorvipath         | 420 µg/1.4 ml  | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 1.4 ml (0.3 mg/ml)        | 2 pre-filled pens + 30 needles |
| EU/1/23/1766/004 | Yorvipath         | 168 µg/0.56 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.56 ml (0.3 mg/ml)       | 2 pre-filled pens              |
| EU/1/23/1766/005 | Yorvipath         | 294 µg/0.98 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.98 ml (0.3 mg/ml)       | 2 pre-filled pens              |
| EU/1/23/1766/006 | Yorvipath         | 420 µg/1.4 ml  | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 1.4 ml (0.3 mg/ml)        | 2 pre-filled pens              |